A detailed history of Jacobs Levy Equity Management, Inc transactions in Mannkind Corp stock. As of the latest transaction made, Jacobs Levy Equity Management, Inc holds 1,947,813 shares of MNKD stock, worth $12.8 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,947,813
Holding current value
$12.8 Million
% of portfolio
0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.01 - $6.7 $9.76 Million - $13.1 Million
1,947,813 New
1,947,813 $12.2 Million
Q3 2017

Nov 14, 2017

SELL
$1.15 - $2.29 $160,615 - $319,835
-139,666 Closed
0 $0
Q2 2017

Nov 09, 2017

BUY
N/A
139,666
139,666 $197,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.7B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.